Chemoinformaics analysis of Nerol-6-O-Alpha-L-Arabinofuranosyl-Beta-D-Glucopyranoside
| Molecular Weight | 448.509 | nRot | 10 |
| Heavy Atom Molecular Weight | 412.221 | nRig | 13 |
| Exact Molecular Weight | 448.231 | nRing | 2 |
| Solubility: LogS | -1.851 | nHRing | 2 |
| Solubility: LogP | 0.06 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 67 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 0 |
| nHA | 10 | APOL | 67.0946 |
| nHD | 6 | BPOL | 43.0595 |
| QED | 0.228 |
| Synth | 4.523 |
| Natural Product Likeliness | 2.181 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.659 |
| Pgp-sub | 0.688 |
| HIA | 0.961 |
| CACO-2 | -5.303 |
| MDCK | 0.000267938 |
| BBB | 0.256 |
| PPB | 0.550894 |
| VDSS | 0.484 |
| FU | 0.288569 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.038 |
| CYP2c19-inh | 0.005 |
| CYP2c19-sub | 0.088 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.149 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.095 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.014 |
| CL | 1.285 |
| T12 | 0.316 |
| hERG | 0.015 |
| Ames | 0.232 |
| ROA | 0.055 |
| SkinSen | 0.036 |
| Carcinogencity | 0.145 |
| EI | 0.01 |
| Respiratory | 0.013 |
| NR-Aromatase | 0.032 |
| Antiviral | Yes |
| Prediction | 0.881587 |